Literature DB >> 7571966

Effusion cytology of hepatocellular carcinoma.

G Falconieri1, F Zanconati, I Colautti, S Dudine, D Bonifacio-Gori, L Di Bonito.   

Abstract

OBJECTIVE: To evaluate effusion cytology on routine smears in patients with hepatocellular carcinoma. STUDY
DESIGN: Filed smears from 106 patients with autopsy-proven hepatocellular carcinoma were retrospectively reviewed for the presence of malignant cells. Morphologic patterns, as well as immunochemical reactivity for a panel of antibodies, were analyzed when feasible.
RESULTS: Malignant cells were identified in 10 cases of ascites and 1 of pleural fluid. Positive smears were variably cellular, with paucicellular, round or linear aggregates of polygonal cells. The cytoplasm was usually evident and very stainable. The nuclei were hyperchromatic or vesicular, with inconspicuous nucleoli. Reactive changes were frequent. Malignant cells were positive for keratins (7/8) and erythropoietin (4/8) and negative for carcinoembryonic antigen (0/8). Concomitant cirrhosis was present in 103 cases (97.1%); all the noncirrhotic cases had malignant cells identifiable in the effusion. Antemortem clinical diagnosis of malignancy was made in 59 cases (55.7%); cytology was the only source of the morphologic diagnosis in most of them.
CONCLUSION: These results indicate that although the yield of hepatocellular carcinoma in effusion cytology is limited, it may be important in the initial assessment of the disease, given the ineligibility of most patients for invasive procedures and the equivocal features of instrumental investigations. Immunocytochemistry may further assist in differentiating doubtful cases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7571966

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Effusion cytology of hepatocellular carcinoma with in situ hybridisation for human albumin.

Authors:  M R Stephen; K Oien; R K Ferrier; R A Burnett
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

2.  Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.

Authors:  Chung-Pin Li; Tze-Sing Huang; Yee Chao; Full-Young Chang; Jacquline Whang-Peng; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

Review 3.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

4.  Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study.

Authors:  Michael J Thrall; Ellen J Giampoli
Journal:  Cytojournal       Date:  2009-08-07       Impact factor: 2.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.